Cagrilintide
Metabolic
A long-acting amylin analog that works synergistically with GLP-1 agonists for appetite regulation and weight management.
Community
0
Tracking
0
Doses Logged
1.2mg/week
Common Dose
—
Adverse Rate
All dosages:1.2mg/week2.4mg/week
Reported Adverse Effects
No adverse effects reported yet
Community Consensus
No consensus claims yet — be the first to contribute
Literature
No studies linked yet — know of one? Share it in the discussion
Discussion
No discussion yet — be the first to share your experience